OpenAlex
PricingAboutJobs
Log inGet started
Work

A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats

HTML

Year: 2014
Type: article
Source: Neuropharmacology
DOI: 10.1016/j.neuropharm.2014.03.004
Authors: Ajeesh Koshy Cherian, Howard Gritton, David E. Johnson, Damon Young, Rouba Kozak, Martin Sarter
Institutions: University of Michigan, Pfizer (United States)
Language: English

Topic: Tryptophan and brain disorders
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Keywords: kynurenine aminotransferase II, kynurenic acid, kynurenine pathway, prefrontal cortex, L-kynurenine, schizophrenia, cognitive impairment, tryptophan metabolism, alpha7 nicotinic acetylcholine receptor
SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, National Institutes of Health, National Institute on Drug Abuse
Award: Postdoctoral Training in the Biology of Drug Abuse
OpenAlex ID: W2037599428
FWCI: 1.576
Cites: 37
Cited by: 60
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security